3Yamamoto, Nasu Y, Saika T, et al.The absorption of pirarubicin in-stilled intravesically immediately after transurethral resection of super-ficial bladder cancer [J] -BJU Int, 2000,86 : 802-804.
5Kobayashi M, Sugaya Y, Yuzawa M, et al. Appropriate intravesical re-tention time of pirarubicin concentration based on its level in tumortissue, anti-tumor effect and side effect in intravesical instillation ther-apy for bladder tumor [J].Gan To Kagaku Ryoho, 1998,25: 1771-1774.
二级参考文献21
1Waters WB. Invasive bladder cancer: where do we go from here? J Urol, 1996, 155:1910-1911.
2Tolley DA, Parrrkar MK, Grigor KM, et al. The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up. J Urol, 1996, 155 : 1233-1238.
3Sylvester RJ, van der Meijden AP, Osterlinck W, et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol, 2006, 49:466- 477.
4Okamura K, Ono Y, Kinukawa S, et al. Randomized study of single early instillation of ( 2" R )4'-O-tetrahydropyranyl- doxorubicin for a single superficial bladder carcinoma. Cancer, 2002, 94:2363-2368.
5Akaza H, Kurth KH, Williams R, et al. Intravesical chemotherapy and immunotherapy for superficial tumour: Basic mechanism of action and future direction. Urol Oncol, 1998, 4 : 121-129.
8Takahashi T, Kushiro A, Nomoto K, et al. Antitumor effects of the intravesical instillation of heat killed cells of the Lactobacillus casei strain Shirota on the murine orthotopic bladder tumor MBT- 2. J Urol, 2001, 166:2506-2511.
9Iguchi H, Teranishi Y, Tone 14 Vesical tissue concentration of pirarubicin after intravesical instillation in rats. Basic Clin Report, 1994, 28: 21-24.
10Yamamoto Y, Nasu Y, Saika T, et al. The absorption of pirarubicin instilled intravesically immediately after transurethral resection of superficial bladder cancer. BJU Int, 2000, 86 : 802-804.
6Akihiro I, Ichiro S,Makoto S. Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephrour eterectomy for upper urinary tract urothelial carcinoma: the triP monotherapy study group trial[J]. J Clin Oncol, 2013,31 (11):1422 1427.
7Sugano O,Shojin, Hatakeyama T,et al. Investigation of reten- tion time of intravesical instillation therapy with pirarubicin (THP)[J]. Gan to Kagaku Ryoho,1996,23(9) : 1169-1174.
